Korean Consulate in Guangzhou Visits Aoyuan Group to Explore Healthcare Collaboration Opportunities
Korean Consulate, MOHW, and KHIDI delegation tours Aoyuan Brand Pavilion and MS ARORA clinic in Guangzhou
Updated: Oct 24, 2019Guangzhou, China — The Deputy Consul General of the Korean Consulate in Guangzhou led an official delegation to visit Aoyuan Group, one of China’s leading integrated lifestyle and healthcare conglomerates (HKEX: 3883), to explore strategic collaboration opportunities in the healthcare and medical beauty sectors.
The visit was hosted by Min Baek, Vice President of Aoyuan Health Life Group, who facilitated discussions and guided the delegation through Aoyuan’s key assets and operations.

According to the welcome message displayed during the visit, the delegation included:
- The Deputy Consul General of the Republic of Korea in Guangzhou
- Representatives from the Korea Health Industry Development Institute (KHIDI)
- Officials from Korea’s Ministry of Health and Welfare
Notably, Ms. Oh from the Ministry of Health and Welfare and Mr. Baek from KHIDI joined the visit, underscoring the Korean government’s strong interest in expanding healthcare collaboration with China.

Exploring Aoyuan’s Healthcare Ecosystem
The delegation first toured the Aoyuan Brand Pavilion, where they were introduced to the group’s integrated business model spanning real estate, wellness, and healthcare services. Aoyuan has been actively expanding into health-focused lifestyle platforms, positioning itself at the intersection of urban living and medical services.

During the walkthrough, discussions focused on:
- Cross-border patient flows between China and Korea
- Integration of medical services with lifestyle platforms
- Opportunities for Korean hospitals and clinics to partner with Chinese ecosystems

Visit to MS ARORA Beauty Clinic (Panyu, Guangzhou)
The delegation also visited MS ARORA, a premium medical aesthetics clinic founded by Aoyuan Group and located in Panyu, Guangzhou.

At MS ARORA, the group observed:
- Clinic operations and patient experience flow
- Technology and treatment offerings in the Chinese aesthetic market
- Branding and positioning strategies for high-end medical beauty services
The visit provided firsthand insight into how Chinese medical aesthetics providers are evolving to meet growing domestic demand, while also opening dialogue on how Korean expertise can integrate into this ecosystem.

Strengthening Korea–China Healthcare Collaboration
This visit marks a meaningful step toward deeper collaboration between Korea and China in healthcare and medical beauty. With strong government participation and private-sector leadership, both sides explored practical pathways to:
- Facilitate cross-border medical tourism
- Enhance trust and transparency in patient acquisition
- Build integrated healthcare platforms connecting Chinese demand with Korean supply

Min Baek (Bai Chengmin), Vice President of Aoyuan Healthy Life Group emphasized the importance of execution-driven partnerships that can translate dialogue into real patient flows and business outcomes.

About Exprivé
Exprivé is building the operating system for global patient acquisition in Korean healthcare. By combining a network of 20,000+ global influencers with medical partnerships, Exprivé connects international patients to trusted Korean clinics through transparent, content-driven discovery and real-time engagement.
From awareness to consultation and conversion, Exprivé enables hospitals to access global demand efficiently while giving patients clarity, trust, and choice in their healthcare journey.
About Exprivé
Exprivé connects expats and international patients with Korea’s top hospitals, ensuring access to world-class medical services at fair and transparent prices. Our platform makes it easy for influencers, medical tourists, and healthcare professionals to navigate Korea’s healthcare system. Stay connected with us for more insights into Korea’s top medical institutions and services.
Exprivé is a government-registered faciliitator for international patients to Korea: A-2025-01-01-5810
